CY1111292T1 - Παρασκευασμα πολλαπλων φασεων για αντισυλληψη βασιζομενο σε φυσικο οιστρογονο - Google Patents

Παρασκευασμα πολλαπλων φασεων για αντισυλληψη βασιζομενο σε φυσικο οιστρογονο

Info

Publication number
CY1111292T1
CY1111292T1 CY20101100913T CY101100913T CY1111292T1 CY 1111292 T1 CY1111292 T1 CY 1111292T1 CY 20101100913 T CY20101100913 T CY 20101100913T CY 101100913 T CY101100913 T CY 101100913T CY 1111292 T1 CY1111292 T1 CY 1111292T1
Authority
CY
Cyprus
Prior art keywords
natural
ostrogen
contraction
phase preparation
ovulatory
Prior art date
Application number
CY20101100913T
Other languages
English (en)
Inventor
Jan Endrikat
Bernd Düsterberg
Original Assignee
Bayer Schering Pharma Aktiengesellschaft
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34979546&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CY1111292(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Bayer Schering Pharma Aktiengesellschaft filed Critical Bayer Schering Pharma Aktiengesellschaft
Publication of CY1111292T1 publication Critical patent/CY1111292T1/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones

Abstract

Η εφεύρεση αναφέρεται σε παρασκεύασμα πολλαπλών φάσεων για αντισύλληψη βασιζόμενο σε φυσικό οιστρογόνο σε συνδυασμό με συνθετικό γεσταγόνο, το οποίο σε σύγκριση με συνήθη αντι-ωορρηκτικά παρασκευάσματα της κατηγορίας αυτής, τα οποία από παλιά έχουν αποδειχθεί αξιόπιστα και ασφαλή για ευρεία χρήση, επιτυγχάνει για όλη τη διάρκεια του κύκλου υψηλότερη αντισυλληπτική ασφάλεια, βελτιώνει την κυκλική συμπεριφορά αιμορραγίας και ελαχιστοποιεί τις παρενέργειες, όπως τάσεις στο στήθος, πονοκεφάλους, καταθλιπτική διάθεση και αλλαγές γενετήσιας ορμής κ.ο. ή τις αποκλείει.
CY20101100913T 2004-04-20 2010-10-14 Παρασκευασμα πολλαπλων φασεων για αντισυλληψη βασιζομενο σε φυσικο οιστρογονο CY1111292T1 (el)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102004019743A DE102004019743B4 (de) 2004-04-20 2004-04-20 Mehrphasenpräparat zur Kontrazeption auf der Basis eines natürlichen Estrogens
EP05730867.8A EP1740163B2 (de) 2004-04-20 2005-04-15 Mehrphasenpräparat zur kontrazeption auf der basis eines natürlichen estrogens

Publications (1)

Publication Number Publication Date
CY1111292T1 true CY1111292T1 (el) 2015-08-05

Family

ID=34979546

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20101100913T CY1111292T1 (el) 2004-04-20 2010-10-14 Παρασκευασμα πολλαπλων φασεων για αντισυλληψη βασιζομενο σε φυσικο οιστρογονο

Country Status (38)

Country Link
US (3) US8071577B2 (el)
EP (1) EP1740163B2 (el)
JP (1) JP4908399B2 (el)
KR (1) KR20060134168A (el)
CN (1) CN1946383B (el)
AR (2) AR048830A1 (el)
AT (1) ATE473734T1 (el)
AU (1) AU2005235418C1 (el)
BR (1) BRPI0510005A (el)
CA (1) CA2561839C (el)
CR (1) CR8695A (el)
CY (1) CY1111292T1 (el)
DE (2) DE102004019743B4 (el)
DK (1) DK1740163T4 (el)
EA (1) EA010313B1 (el)
EC (1) ECSP067000A (el)
ES (1) ES2348038T5 (el)
GT (1) GT200500093A (el)
HK (1) HK1099701A1 (el)
HR (1) HRP20100513T4 (el)
IL (2) IL178510A (el)
ME (1) ME01183B (el)
MX (1) MXPA06012213A (el)
MY (1) MY143669A (el)
NO (1) NO344098B1 (el)
NZ (1) NZ550417A (el)
PA (1) PA8630901A1 (el)
PE (1) PE20060308A1 (el)
PL (1) PL1740163T5 (el)
PT (1) PT1740163E (el)
RS (1) RS51434B2 (el)
SI (1) SI1740163T2 (el)
SV (1) SV2006002090A (el)
TW (1) TWI351960B (el)
UA (1) UA83915C2 (el)
UY (1) UY28863A1 (el)
WO (1) WO2005102247A2 (el)
ZA (1) ZA200609594B (el)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102004019743B4 (de) * 2004-04-20 2008-11-27 Bayer Schering Pharma Aktiengesellschaft Mehrphasenpräparat zur Kontrazeption auf der Basis eines natürlichen Estrogens
PT1937274E (pt) * 2005-10-13 2012-05-28 Bayer Pharma AG Utilização de valerato de estradiol em combinação com dienogest para a terapia oral da hemorragia uterina disfuncional em conjunto com uma contracepção oral
ATE424828T1 (de) * 2005-10-13 2009-03-15 Bayer Schering Pharma Ag Verwendung von estradiolvalerat in kombination mit dienogest zur oralen therapie der dysfunktionellen uterinen blutung in einheit mit einer oralen kontrazeption
US8153616B2 (en) 2005-10-17 2012-04-10 Bayer Pharma Aktiengesellschaft Combination preparation for oral contraception and oral therapy of dysfunctional uterine bleeding containing estradiol valerate and dienogest and method of using same
ES2558030T3 (es) 2006-03-02 2016-02-01 Warner Chilcott Company, Llc Método anticonceptivo oral multifásico de ciclo prolongado
DE102006010329A1 (de) * 2006-03-06 2007-09-13 Höltge, Michael, Dipl.-Med. Hormonelles Kontrazeptivum auf der Basis eines Estrogens, eines Gestagens oder einer Kombination von Estrogenen und Gestagenen unter der Zugabe von Testosteron
EP1930010A1 (de) * 2006-10-20 2008-06-11 Bayer Schering Pharma Aktiengesellschaft Verwendung von Estradiolvalerat oder 17ß-Estradiol in Kombination mit Dienogest zur oralen Therapie für den Erhalt und/oder die Steigerung der weiblichen Libido
US20090117184A1 (en) * 2007-11-05 2009-05-07 Sabine Fricke Use of a gestagen in combination with an estrogen and one or more pharmaceutically acceptable auxiliary agents/excipients for lactose-free oral contraception
TW201306825A (zh) * 2011-05-11 2013-02-16 Kirax Corp 狀況治療之改良套裝

Family Cites Families (52)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU4168068A (en) 1969-07-22 1971-01-28 Unisearch Limited Improvements in or relating to oral contraceptives
US3639600A (en) * 1969-08-28 1972-02-01 Upjohn Co Process of establishing cyclicity in a human female
US3795734A (en) * 1970-04-20 1974-03-05 American Home Prod Cyclic regimen of hormone administration for contraception
US4066757A (en) * 1973-03-26 1978-01-03 Ortho Pharmaceutical Corporation Oral contraceptive regimen
DE2365103C3 (de) 1973-12-21 1980-08-28 Schering Ag, 1000 Berlin Und 4619 Bergkamen V erwendung von Hormonen zur Kontrazeption
DE2431704A1 (de) 1974-07-02 1976-01-22 Asche Ag Stufenkombinationspraeparate per kontrazeption
DE2645307A1 (de) 1976-10-05 1978-04-06 Schering Ag Neue mittel und neue methoden zur behandlung klimakterischer ausfallerscheinungen
JPS6019734B2 (ja) 1977-05-12 1985-05-17 三共株式会社 安定なプロスタグランジンｅ類製剤の製法
US4272270A (en) 1979-04-04 1981-06-09 Petrochem Consultants, Inc. Cryogenic recovery of liquid hydrocarbons from hydrogen-rich
NL8001593A (nl) * 1980-03-18 1981-10-16 Akzo Nv Meerfasisch combinatiepreparaat voor orale anticonceptie.
US4390531A (en) * 1981-08-10 1983-06-28 Syntex Pharmaceuticals International Ltd. Method of contraception using peak progestogen dosage
US4921843A (en) * 1988-10-20 1990-05-01 Pasquale Samuel A Contraception system and method
US4544554A (en) * 1983-09-26 1985-10-01 Ortho Pharmaceutical Corporation Triphasic oral contraceptive
US4616006A (en) * 1983-09-26 1986-10-07 Ortho Pharmaceutical Corporation Triphasic oral contraceptive
US4530839A (en) * 1983-09-26 1985-07-23 Ortho Pharmaceutical Corporation Triphasic oral contraceptive
US4628051A (en) * 1983-09-26 1986-12-09 Ortho Pharmaceutical Corporation Triphasic oral contraceptive
DE3341638A1 (de) 1983-11-17 1984-05-03 Hermann Dr.rer.nat. 8000 München Heßlinger Dreiphasen-praeparat zur empfaengnisverhuetung aus ethinyloestradiol und lynestrenol
DE3347125A1 (de) * 1983-12-22 1985-07-11 Schering AG, 1000 Berlin und 4709 Bergkamen Mehrstufenkombinationspraeparat und seine verwendung zur oralen kontrazeption
AU581486B2 (en) 1985-12-30 1989-02-23 Warner-Lambert Company Graduated estrogen contraceptive
IE61236B1 (en) 1986-07-15 1994-10-19 American Home Prod Combination dosage form for pre-menopausal women
CA2005933A1 (en) 1989-01-09 1990-07-09 Jesse Hipps, Sr. Photohardenable composition containing five member aromatic group with imine moiety
IE71203B1 (en) * 1990-12-13 1997-02-12 Akzo Nv Low estrogen oral contraceptives
DE4104385C1 (el) 1991-02-09 1992-08-13 Marika Dr.Med. 6509 Framersheim De Ehrlich
DE4224534A1 (de) 1992-07-24 1994-01-27 Marika Dr Med Ehrlich Ovulationshemmendes Mittel zur hormonalen Kontrazeption
DE4308406C1 (de) 1993-03-12 1994-06-16 Jenapharm Gmbh Kombinationspräparat zur Kontrazeption
DE4313926A1 (de) * 1993-04-28 1994-11-03 Jenapharm Gmbh Pharmazeutisches Mehrphasenpräparat zur hormonalen Kontrazeption
DE4339934C2 (de) 1993-05-07 1995-05-24 Klaus Dr Med Umbreit Ovulationshemmendes Mittel zur hormonalen Kontrazeption
NL9301562A (nl) 1993-09-09 1995-04-03 Saturnus Ag Preparaat voor substitutietherapie.
DE4344462C2 (de) 1993-12-22 1996-02-01 Schering Ag Zusammensetzung für die Empfängnisverhütung
DE4429374C1 (de) 1994-08-12 1996-02-01 Jenapharm Gmbh Pharmazeutische Präparate zur Kontrazeption/Hormonsubstitution mit biogener Estrogenkomponente
DE19525017A1 (de) * 1995-06-28 1997-01-02 Schering Ag Pharmazeutisches Kombinatonspräparat, Kit und Methode zur hormonalen Kontrazeption
DE19540253C2 (de) * 1995-10-28 1998-06-04 Jenapharm Gmbh Mehrphasenpräparat zur Kontrazeption auf der Basis natürlicher Estrogene
US20050032756A1 (en) * 1995-10-28 2005-02-10 Michael Dittgen Multistage preparation for contraception based on natural estrogens
WO1998004268A1 (en) 1996-07-26 1998-02-05 American Home Products Corporation Oral contraceptive
CN1186023C (zh) * 1996-07-26 2005-01-26 惠氏公司 双相避孕方法及包含孕激素和雌激素组合物的药剂盒
BR9710566A (pt) 1996-07-26 1999-08-17 American Home Prod M-todo anticoncepcional monof sico e um kit compreendendo uma combina-Æo de uma progestina e estrog-nio
DE19654609A1 (de) * 1996-12-20 1998-06-25 Schering Ag Therapeutische Gestagene zur Behandlung von Premenstrual Dysphoric Disorder
US6987101B1 (en) * 1996-12-20 2006-01-17 Schering Aktiengesellschaft Therapeutic gestagens for the treatment of premenstrual dysphoric disorder
US5898032A (en) 1997-06-23 1999-04-27 Medical College Of Hampton Roads Ultra low dose oral contraceptives with less menstrual bleeding and sustained efficacy
US6312772B1 (en) * 1997-10-20 2001-11-06 Hoechst Celanese Corporation Multilayer laminate formed from a substantially stretched non-molten wholly aromatic liquid crystalline polymer and non-polyester thermoplastic polymer
DE19908762A1 (de) * 1999-02-18 2000-08-31 Jenapharm Gmbh Verwendung von Dienogest in hoher Dosierung
DE10045380A1 (de) 2000-09-14 2002-04-04 Schering Ag Verfahren zur Kontrazeption und dessen Darreichungsform
US6699820B2 (en) * 2001-03-02 2004-03-02 Hartmut Ulrich Bielefeldt Method for making a superconductor with enhanced current carrying capability
KR20040037097A (ko) * 2001-09-29 2004-05-04 솔베이 파머슈티컬스 게엠베하 에스트로겐/게스타겐 조합 제제 및 그 이용
EP1462106A1 (en) 2003-03-28 2004-09-29 Pantarhei Bioscience B.V. Pharmaceutical compositions and kits comprising 17-beta-estradiol and a progesteron for the treatment of gynecological disorders
WO2004112797A1 (en) 2003-06-25 2004-12-29 Schering Ag Hormone replacement- and depression therapy comprising dienogest
DE102004019743B4 (de) 2004-04-20 2008-11-27 Bayer Schering Pharma Aktiengesellschaft Mehrphasenpräparat zur Kontrazeption auf der Basis eines natürlichen Estrogens
EP2392333A1 (en) * 2004-10-07 2011-12-07 Teva Women's Health, Inc. Methods of hormonal treatment utilizing ascending-dose extended cycle regimens
TW200726473A (en) 2005-06-28 2007-07-16 Wyeth Corp Compositions and methods for treatment of cycle-related symptoms
ATE424828T1 (de) 2005-10-13 2009-03-15 Bayer Schering Pharma Ag Verwendung von estradiolvalerat in kombination mit dienogest zur oralen therapie der dysfunktionellen uterinen blutung in einheit mit einer oralen kontrazeption
US8153616B2 (en) * 2005-10-17 2012-04-10 Bayer Pharma Aktiengesellschaft Combination preparation for oral contraception and oral therapy of dysfunctional uterine bleeding containing estradiol valerate and dienogest and method of using same
EP1930010A1 (de) * 2006-10-20 2008-06-11 Bayer Schering Pharma Aktiengesellschaft Verwendung von Estradiolvalerat oder 17ß-Estradiol in Kombination mit Dienogest zur oralen Therapie für den Erhalt und/oder die Steigerung der weiblichen Libido

Also Published As

Publication number Publication date
HRP20100513T1 (en) 2010-11-30
KR20060134168A (ko) 2006-12-27
PE20060308A1 (es) 2006-05-25
US20110124612A1 (en) 2011-05-26
ES2348038T3 (es) 2010-11-29
PL1740163T3 (pl) 2010-12-31
AU2005235418C1 (en) 2015-05-21
CN1946383B (zh) 2010-06-09
SI1740163T1 (sl) 2010-11-30
EP1740163B2 (de) 2020-01-15
JP4908399B2 (ja) 2012-04-04
NO20065292L (no) 2007-01-17
DE102004019743B4 (de) 2008-11-27
RS51434B (en) 2011-04-30
NZ550417A (en) 2010-01-29
CN1946383A (zh) 2007-04-11
EP1740163B1 (de) 2010-07-14
PT1740163E (pt) 2010-09-28
AR048830A1 (es) 2006-05-31
NO344098B1 (no) 2019-09-02
IL178510A0 (en) 2007-02-11
UY28863A1 (es) 2005-11-30
GT200500093A (es) 2006-04-17
MXPA06012213A (es) 2007-01-17
ATE473734T1 (de) 2010-07-15
HK1099701A1 (en) 2007-08-24
TWI351960B (en) 2011-11-11
WO2005102247A2 (de) 2005-11-03
ECSP067000A (es) 2006-12-29
DE102004019743A1 (de) 2005-11-24
AU2005235418B2 (en) 2009-08-06
MY143669A (en) 2011-06-30
IL239861A0 (en) 2015-08-31
RS51434B2 (sr) 2020-11-30
PL1740163T5 (pl) 2020-10-05
CR8695A (es) 2008-07-29
CA2561839C (en) 2009-09-29
ES2348038T5 (es) 2020-09-14
WO2005102247A3 (de) 2006-01-12
ME01183B (me) 2013-03-20
EA200601844A1 (ru) 2007-04-27
IL178510A (en) 2015-08-31
TW200534860A (en) 2005-11-01
PA8630901A1 (es) 2006-05-16
BRPI0510005A (pt) 2007-09-18
CA2561839A1 (en) 2005-11-03
HRP20100513T4 (hr) 2020-10-02
SI1740163T2 (sl) 2020-04-30
EP1740163A2 (de) 2007-01-10
ZA200609594B (en) 2008-04-30
JP2007533681A (ja) 2007-11-22
US8071577B2 (en) 2011-12-06
SV2006002090A (es) 2006-02-15
DK1740163T3 (da) 2010-10-18
AR084229A2 (es) 2013-05-02
DK1740163T4 (da) 2020-04-06
US20070259840A1 (en) 2007-11-08
DE502005009904D1 (de) 2010-08-26
US20100173877A1 (en) 2010-07-08
EA010313B1 (ru) 2008-08-29
UA83915C2 (ru) 2008-08-26
AU2005235418A1 (en) 2005-11-03

Similar Documents

Publication Publication Date Title
CY1111292T1 (el) Παρασκευασμα πολλαπλων φασεων για αντισυλληψη βασιζομενο σε φυσικο οιστρογονο
CY1121215T1 (el) Αντιικα εμβολια με βελτιωμενη κυτταρικη ανοσογονικοτητα
CY1122337T1 (el) Παραγωγα σουλφamοϋλθεiοφaiνamiδιου και η χρηση αυτων ως φαρμακων για τη θεραπευτικη αντιμετωπιση της ηπατιτιδας β
CY1121789T1 (el) Νεες ανοσοενισχυτικες συνθεσεις
CY1122372T1 (el) Συνθεση ρινικου εμβολιου γριπης
CY1125057T1 (el) Anti-cd277 αντισωματα και χρησεις αυτων
CY1120662T1 (el) Παραγωγα πυρρολαμιδιου υποκατεστημενου γλυοξαμιδιου και η χρηση αυτων ως φαρμακων για τη θεραπευτικη αντιμετωπιση της ηπατιτιδας β
CY1118492T1 (el) Φαρμακοτεχνικες μορφες εμβολιου norovirus
CY1123563T1 (el) Ανοσογονικα wt-1 πεπτιδια και μεθοδοι χρησης αυτων
CY1122329T1 (el) Anti-siglec-8 αντισωματα και μeθοδοι χρhσεως αυτων
CY1119981T1 (el) Λιπιδιωμενα παραγωγα ιμιδαζοκινολινης
CY1117689T1 (el) Συνθεσεις που περιλαμβανουν πνευμονιοκοκκικα αντιγονα
CY1118171T1 (el) Θεραπευτικη αντιμετωπιση της φαiνυλκετονουρiας me βη4
CY1116904T1 (el) Εμβολιο
CY1106532T1 (el) Ετερολογος εκφραση των πρωτεϊνων της neisseria
CO7170160A2 (es) Nuevas 6-aminoacido-heteroarildihidropirimidinas para el tratamiento y profilaxis de la infección del virus de la hepatitis b
CY1123056T1 (el) Νεα μορφη χορηγησης της ρασεκαδοτριλης
CY1112589T1 (el) Ανοσογονος συνθεση που περιεχει ανοσοενισχυτικο
CY1113738T1 (el) Εμβολια κατα της γριπης χαμηλης περιεκτικοτητας σε προσθετα
CY1125338T1 (el) Λιποκατιονικα δενδριμερη και χρησεις εξ αυτων
CR10732A (es) Uso de valerato de estradiol o 17 b- estradiol en combinacion con dienogest en una terapia oral para mantener y / o incrementar la libido femenina
CY1107485T1 (el) 3-θειομεθυλπυραζoλες ως παρασιτοκτoνα
CY1112614T1 (el) Αγωγη με κλαδριβινη για τη θεραπεια πολλαπλης σκληρυνσης
MX2015007753A (es) Composicion de vacunas para sujetos intactos.
CY1125143T1 (el) Νεα αλατα νιλοτινιμπης και πολυμορφα αυτων